Verreault, M. Demers
89  results:
Search for persons X
?
 
?
3

P10.17.B Androgen receptor signalling has independent progn..:

Birzu, C ; Boussier, J ; Belin, L...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii52-ii53 , 2022
 
?
4

P13.11 Transcriptional CDK inhibitors, CYC065 and THZ1 prom..:

Juric, V ; Duessmann, H ; Jahns, H...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii34-ii35 , 2021
 
?
 
?
7

Determination of an optimal dosing schedule for combining I..:

Verreault, M. ; Wehbe, M. ; Strutt, D....
Journal of Controlled Release.  220 (2015)  - p. 348-357 , 2015
 
?
9

Profiling Serum Bile Acid Glucuronides in Humans: Gender Di..:

Trottier, J ; Perreault, M ; Rudkowska, I...
Clinical Pharmacology & Therapeutics.  94 (2013)  4 - p. 533-543 , 2013
 
?
10

Irinophore C™, a lipid-based nanoparticulate formulation of..:

Verreault, M. ; Strutt, D. ; Masin, D....
Journal of Controlled Release.  158 (2012)  1 - p. 34-43 , 2012
 
?
11

Efficacité d'une thérapie cognitivo-comportementale auprès ..:

Verreault, M. ; Berthiaume, C.
Journal de Thérapie Comportementale et Cognitive.  20 (2010)  3 - p. 93-98 , 2010
 
?
12

Role of the Endothelin System in Secondary Pulmonary Hypert..:

Battistini, B ; Verreault, M ; Ayach, B...
Journal of Cardiovascular Pharmacology.  44 (2004)  Supplement 1 - p. S386-S389 , 2004
 
?
 
1-15